Year | Volume (Price x Shares) | Change |
---|---|---|
2023 | $0.64 M | -92.96% |
2022 | $9.13 M | 32.85% |
2021 | $6.87 M | 0.68% |
2020 | $6.83 M | 135.57% |
2019 | $2.89 M | -77.1% |
2018 | $12.65 M | 286.72% |
2017 | $3.27 M | -4.51% |
2016 | $3.42 M | -61.82% |
2015 | $8.97 M | -2.72% |
2014 | $9.22 M | 42.79% |
2013 | $6.46 M |
Company | FTD volume (3months) | FTD volume (1 year) | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $0.30 B | $0.50 B | ๐บ๐ธ USA |
![]() Novartis NVS | $10.06 M | $52.33 M | ๐จ๐ญ Switzerland |
![]() Pfizer PFE | $39.54 M | $0.40 B | ๐บ๐ธ USA |
![]() Abbott Laboratories ABT | $22.63 M | $97.39 M | ๐บ๐ธ USA |
![]() Biogen BIIB | $29.51 M | $74.91 M | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | $48.83 M | $0.15 B | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | $3.3 M | $66.04 M | ๐ฌ๐ง UK |
![]() Seagen
SGEN | $18.86 M | $70.56 M | ๐บ๐ธ USA |
![]() Curis CRIS | $0.74 M | $1.11 M | ๐บ๐ธ USA |
![]() Teva Pharmaceutical Industries TEVA | $12.76 M | $38.36 M | ๐ฎ๐ฑ Israel |